Conditions: survodutide · 8 mg/mL.
I am trying to do this correctly the first time rather than learn it by getting it wrong.
I have already made one mistake here that cost me a vial, so I am being deliberately careful.
What is the correct sequence, and where is the step that people usually skip?
Nobody has published a cycle count, and at 8 mg/mL the concentration tells you what a wrong guess costs: a 0.1 mL aliquot holds 0.8 mg and every microlitre is 8 µg. Damage from freezing is not gradual attrition — it is concentrated at the phase transitions, where ice excludes solute and the unfrozen fraction climbs well above 8 mg/mL for as long as the transition lasts. Two slow cycles can therefore do more than four fast ones, which is why a cycle count is the wrong unit in the first place. The way to make the number one is to make it one: split at reconstitution into single-draw aliquots, label each with 8 mg/mL and the date, and never thaw a container you will refreeze.
Start with how many cycles are actually planned, because one or two are immaterial and ten are not.
Let a frozen vial reach room temperature before opening it. Opening a cold vial in humid air condenses water into the cake, which raises residual moisture and undoes what lyophilisation achieved.
| State | Condition | Usable window | Basis |
|---|---|---|---|
| Lyophilised solid | −20 °C, sealed, dry | 24–36 months | Supplier guidance |
| Lyophilised solid | 2–8 °C, sealed | 12–24 months | Supplier guidance |
| Lyophilised solid | 25 °C, sealed | 4–8 weeks | Extrapolated (Arrhenius) |
| Lyophilised solid | 40 °C, sealed | 1–2 weeks | Extrapolated |
| Solution, preserved | 2–8 °C | 28 days | USP microbiological convention |
| Solution, preserved | 25 °C | 3–7 days | Extrapolated |
| Solution, unpreserved | 2–8 °C | 24 hours | USP microbiological convention |
Windows for the solid state are chemical; windows for solution are microbiological and usually shorter than the chemical limit.
Thaw slowly at room temperature or in the refrigerator rather than in warm water. Rapid warming creates local thermal and concentration gradients that promote aggregation.
Selective crystallisation of sodium phosphate buffer components producing large pH shifts on freezing is a classical result in the lyophilisation literature.
Dry powder tolerates cycles far better than solution does.
edited 8 Aug 2026 by lyoph_cake — corrected a unit error in the worked example
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemAnswer first: each freeze-thaw cycle costs something through aggregation and pH shift, so the mitigation is aliquoting rather than choosing a better freezer.
A dry lyophilised powder is much less affected by a temperature cycle because there is no liquid phase for anything to concentrate into. Condensation on a cold vial opened warm is the real risk there.
Never refreeze a thawed aliquot. The whole point of aliquoting is that the aliquot is single-use, and refreezing it discards the benefit.
Cryoconcentration of solutes at the ice front is a well-documented mechanism in freeze-thaw damage to proteins and peptides.
Aliquot before the first freeze. That is the whole answer.
Answering this needs to know whether the material is dry or in solution, since a dry powder is largely indifferent to a temperature cycle.
Count cycles rather than worrying about degrees. Minus twenty and minus eighty differ far less than one cycle and five do.
Specifically, the mitigation is aliquoting. Divide the reconstituted solution into single-use volumes before the first freeze, and each aliquot then experiences exactly one cycle.
Condensation onto cold lyophilised material on opening is a recognised handling error and is the basis for the equilibrate-before-opening rule.
Let a frozen vial reach room temperature before opening, or you condense water into it.
Buffer components crystallise at different rates during freezing, which shifts pH locally by a surprising amount.
Buffer salts crystallise at different points during freezing. Sodium phosphate is the classic example: the dibasic form crystallises first and the pH of the residual liquid falls by several units. That pH excursion is the real damage in many cases.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Thaw slowly and never refreeze an aliquot.
The relevant detail is that this is one of the few handling questions with a genuinely quantitative literature behind it.
During freezing, solutes are excluded from the ice lattice and concentrate into the residual liquid. Local concentrations can rise many-fold, which promotes aggregation independently of temperature.
Aliquoting to eliminate repeated cycles is standard laboratory practice for exactly this reason.
Aliquoting itself is a handling step and introduces its own contamination opportunity.
Count cycles, not degrees. The cycle is the damaging event.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.